福利视频

福利视频 Appoints Dr. Matthew Sleeman as Chief Scientific Officer

福利视频 Announces Licensing of a Novel Inflammatory Disease Target from its RAFT Platform

福利视频 Expands Leadership Team and Appoints Head of Development and General Counsel

福利视频 Announces License and Research Collaboration with MSD to Identify Novel Targets for Inflammatory Diseases

福利视频 Awarded Significant Grant from Innovate UK鈥檚 Prestigious Cancer Therapeutics Program to Accelerate the Path to the Clinic for MST-0300

Mestag Presents Preclinical Data at AACR on its M300 Program, a Conditionally Active LTBR Agonist Designed to Induce Tertiary Lymphoid Structures in Tumors

福利视频鈥� M300 Program, Designed to Conditionally Induce Tertiary Lymphoid Structures in Tumors, Selected for Late-Breaking Poster Presentation at AACR Annual Meeting

福利视频 to Present at Evercore ISI 2024 Emerging Biotech Conference

福利视频 Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its Lead Oncology Program

福利视频 and VIB enter into an exclusive partnership in oncology

福利视频 appoints Prof. Ton Logtenberg as Chair

福利视频 founding investigator Prof. David A. Tuveson elected to US National Academy of Medicine

Fierce Biotech names 福利视频 as one of its 鈥淔ierce 15鈥� Biotech Companies of 2021

福利视频 Extends Seed Financing to $45 Million and Welcomes New Investors Forbion, GV (formerly Google Ventures) and Northpond Ventures

福利视频 announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease

福利视频 launches with seed financing of $11 million to develop therapeutics targeting activated fibroblast populations across inflammatory disease and cancer

福利视频 congratulates Founder Professor David A. Tuveson upon his appointment as 2021 President of The American Association for Cancer Research